Endurance Wealth Management, Inc. Edwards Lifesciences Corp Transaction History

Endurance Wealth Management, Inc.

$731 Million
Q2 2023

A detailed history of Endurance Wealth Management, Inc. transactions in Edwards Lifesciences Corp stock. As of the latest transaction made, Endurance Wealth Management, Inc. holds 231,099 shares of EW stock, worth $15.7 Million. This represents 2.98% of its overall portfolio holdings.

Number of Shares

231,099

Previous 231,489 0.17%

Holding current value

$15.7 Million

Previous $19.2 Million 13.83%

% of portfolio

2.98%

Previous 2.71%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 09, 2023	SELL	$81.41 - $94.33 $31,749 - $36,788	-390 Reduced 0.17%	231,099 $21.8 Million
Q1 2023 May 02, 2023	SELL	$74.26 - $84.51 $49,754 - $56,621	-670 Reduced 0.29%	231,489 $19.2 Million
Q4 2022 Feb 01, 2023	SELL	$68.3 - $87.44 $172,457 - $220,786	-2,525 Reduced 1.08%	232,159 $17.3 Million
Q3 2022 Oct 21, 2022	SELL	$82.37 - $107.29 $59,224 - $77,141	-719 Reduced 0.31%	234,684 $19.4 Million
Q2 2022 Jul 20, 2022	SELL	$86.5 - $128.27 $54,841 - $81,323	-634 Reduced 0.27%	235,403 $22.4 Million
Q1 2022 Apr 20, 2022	BUY	$101.96 - $128.34 $609,007 - $766,574	5,973 Added 2.6%	236,037 $27.8 Million
Q4 2021 Jan 19, 2022	SELL	$106.37 - $130.68 $582,375 - $715,473	-5,475 Reduced 2.32%	230,064 $29.8 Million
Q3 2021 Oct 28, 2021	SELL	$102.91 - $122.75 $440,146 - $525,001	-4,277 Reduced 1.78%	235,539 $26.7 Million
Q2 2021 Aug 04, 2021	SELL	$83.84 - $104.76 $163,404 - $204,177	-1,949 Reduced 0.81%	239,816 $24.8 Million
Q1 2021 May 05, 2021	SELL	$78.68 - $90.67 $95,674 - $110,254	-1,216 Reduced 0.5%	241,765 $20.2 Million
Q4 2020 Jan 15, 2021	SELL	$71.69 - $91.23 $101,728 - $129,455	-1,419 Reduced 0.58%	242,981 $22.2 Million
Q3 2020 Oct 27, 2020	SELL	$67.19 - $87.44 $242,219 - $315,221	-3,605 Reduced 1.45%	244,400 $19.5 Million
Q2 2020 Jul 14, 2020	BUY	$57.54 - $76.95 $9.48 Million - $12.7 Million	164,682 Added 197.64%	248,005 $17.1 Million
Q1 2020 May 11, 2020	SELL	$52.41 - $81.0 $33,489 - $51,759	-639 Reduced 0.76%	83,323 $15.7 Million
Q4 2019 Jan 14, 2020	SELL	$71.7 - $82.09 $25,812 - $29,552	-360 Reduced 0.43%	83,962 $19.6 Million
Q3 2019 Oct 18, 2019	SELL	$61.55 - $75.43 $253,832 - $311,073	-4,124 Reduced 4.66%	84,322 $18.5 Million
Q2 2019 Jul 30, 2019	SELL	$55.74 - $64.41 $35,952 - $41,544	-645 Reduced 0.72%	88,446 $16.3 Million
Q1 2019 May 01, 2019	SELL	$47.89 - $64.05 $84,382 - $112,856	-1,762 Reduced 1.94%	89,091 $17 Million
Q4 2018 Jan 14, 2019	SELL	$46.41 - $56.94 $61,632 - $75,616	-1,328 Reduced 1.44%	90,853 $13.9 Million
Q3 2018 Oct 10, 2018	SELL	$45.7 - $58.03 $105,018 - $133,352	-2,298 Reduced 2.43%	92,181 $16 Million
Q2 2018 Aug 02, 2018	SELL	$42.45 - $51.3 $99,672 - $120,452	-2,348 Reduced 2.42%	94,479 $13.8 Million
Q1 2018 Apr 19, 2018	SELL	$37.19 - $47.45 $61,400 - $78,339	-1,651 Reduced 1.68%	96,827 $13.5 Million
Q4 2017 Jan 18, 2018	BUY	$33.79 - $39.39 $7,940 - $9,256	235 Added 0.24%	98,478 $11.1 Million
Q3 2017 Oct 19, 2017	BUY	$36.29 - $38.83 $3.57 Million - $3.81 Million	98,243	98,243 $10.7 Million

Others Institutions Holding EW

# of Institutions

1,351

Shares Held

455M

Call Options Held

9.76M

Put Options Held

3.92M

View Full List

About Edwards Lifesciences Corp

Ticker EW
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 618,259,968
Market Cap $41.9B
Description
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...

More about EW

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Endurance Wealth Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Endurance Wealth Management, Inc. with notifications on news.

Account

Endurance Wealth Management, Inc. Edwards Lifesciences Corp Transaction History